The title 21 CFR [Code of Federal Regulations] PART 11 is a regulation act established by United States’ FDA [Food & Drug Administration] for electronic records and electronic signatures. This compliance defines the criteria under which the e-Signatures and electronic records are considered equivalent to the paper records and the hand-written wet signatures. This regulation caters to the security concerns about the management, storage and retrieval of electronic records and signatures by users of industries like biotechnology, pharma, and medical equipment manufacturers in this digital age.
Cygnature provides a secure, workflow-based solution for managing electronic records and signatures. Designed according to industry best practices and regulatory guidelines, it is validated and certified by an FDA-authorized consulting agency in the USA. This ensures data integrity through advanced encryption mechanisms, safeguarding the data.